Dr. Ingrid E. Roseborough, MD

Dr. Roseborough practices at Ingrid Roseborough, MD in Oakland, California.

Dr. Roseborough's NPI, 1972636272, was assigned on March 14, 2007. Dr. Roseborough graduated from University of Chicago, Pritzker School of Medicine in 2004. Dr. Roseborough holds California license A92548.

Dr. Roseborough's primary practice is Ingrid Roseborough, MD, at 3300 Webster St, Oakland, CA 94609 in Alameda County. The practice phone is (510) 452-4900.

Dr. Roseborough's primary practice is Ingrid Roseborough, MD in Oakland, California. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Roseborough to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roseborough practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Roseborough's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Roseborough's licenses on file in 2 states: California and Iowa.

CMS data shows 2,707 Medicare services from Dr. Roseborough across 16 procedure codes in 2024, for 625 Medicare patients. Medicare paid $143,326 for them. Every service was in an office.

CMS counts 625 Medicare patients who saw Dr. Roseborough in 2024. The largest group is 65 to 74, with 289 patients. 75% of them have high cholesterol, and 56% have high blood pressure. Their average risk score is 0.78, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Roseborough's median patient age at 57, with 59% women.

In 2024, Dr. Roseborough wrote 705 Medicare Part D claims for 261 patients. 96% of them were for generic drugs. CMS names the drug for 596 of them, across 17 drugs with 11 or more claims each, at $13,818 in total drug cost. In 2023, CMS named 545 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Roseborough for performance year 2024, reported individually. Dr. Roseborough accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roseborough as offering telehealth. CMS counts 1,006 procedures of removal of skin lesions by Dr. Roseborough, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Roseborough. Dr. Roseborough's most frequent co-authors are Wilma F. Bergfeld, MD, Valerie Dawn Callender, MD and Brittany Craiglow, MD.

CMS Open Payments shows 616 general payments to Dr. Roseborough from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Pfizer Inc. paid the most, $20,082.

Dr. Roseborough graduated from University of Chicago, Pritzker School of Medicine in 2004.